NCT03036943View on ClinicalTrials.gov

Fluciclovine (18F) Imaging of Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

December 4, 2018

Study Completion Date

December 4, 2018

Conditions
Breast Cancer
Interventions
RADIATION

Fluciclovine

Fluciclovine (18F) PET/CT scan completed \>= 48 hours prior to surgical resection for breast cancer

Trial Locations (1)

OX3 7LE

Churchill Hospital, Oxford

Sponsors

Collaborators (1)

Blue Earth Diagnostics
All Listed Sponsors
collaborator

Blue Earth Diagnostics

INDUSTRY

lead

University of Oxford

OTHER